---
document_datetime: 2026-02-17 17:58:38
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/vevzuo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: vevzuo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6578145
conversion_datetime: 2026-02-21 12:19:59.332197
docling_version:
  docling-serve: 1.13.0
  docling-jobkit: 1.11.0
  docling: 2.74.0
  docling-core: 2.65.1
  docling-ibm-models: 3.11.0
  docling-parse: 5.3.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.3-arm64-arm-64bit-Mach-O
---
## Vevzuo

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Article 61(3) /      | - Notification acc. Article 61(3) - Accepted | 13/02/2026                          |                                             | PL                               |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000326544                      | Update of the package leaflet with revised contact details of local representatives.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |                        |                   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------------------|-------------------|
| Variation type IB /                   | B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.e Other changes to a test procedure (including replacement or addition) for the active substance or a starting material/intermediate - Accepted                                                                                                                                                                                                                                                                                                                                                       | 11/11/2025 |                        | EMA/VR/0000307328 |
| Variation type IB / EMA/VR/0000290491 | This was an application for a group of variations. B.II.e.5.a Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - B.II.e.5.a.2 Change outside the range of the currently approved pack sizes - Accepted B.II.e.5.a Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - B.II.e.5.a.1 Change within the range of the currently approved pack sizes - Accepted B.II.e.5.a.2 (Type IB) - To add a new pack- size of 4 vials for Vevzuo 120 mg solution for injection (EU/1/25/1945/003). The annexes are updated accordingly. In addition, the MAH took the opportunity to implement editorial changes to change the footer font in | 28/08/2025 | SmPC, Labelling and PL |                   |

<div style=\"page-break-after: always\"></div>

| the SmPC and the page numbering format in Annex A. B.II.e.5.a.1 (Type IA_IN) - To add a new pack-size of 3 vials for Vevzuo 120 mg solution for injection (EU/1/25/1945/002). The annexes are updated accordingly.   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|